Form D — IN8BIO, INC.
0001231919-25-000676 · filed Dec 30, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $40,239,043
- Reported amount sold
- $20,119,049
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- IN8BIO, INC.
- CIK
- 1740279
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- EMPIRE STATE BUILDING
NEW YORK, New York 10118 - Phone
- (646) 600-6438
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
William Ho · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Patrick McCall · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Alan S. Roemer · DirectorNew York, New York Find on LinkedIn ↗
-
Peter Brandt · DirectorNew York, New York Find on LinkedIn ↗
-
Emily R. Fairbairn · DirectorNew York, New York Find on LinkedIn ↗
-
Jeremy Graff · DirectorNew York, New York Find on LinkedIn ↗
-
Luba Greenwood · DirectorNew York, New York Find on LinkedIn ↗
-
Corinne Epperly · DirectorNew York, New York Find on LinkedIn ↗
-
Lawrence Lamb · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Kate Rochlin · Executive OfficerNew York, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗